Clinical Trial Update: Clinical Efficacy of Fosfomycin Trometamol Per os in the Treatment of Documented Male Urinary Tract Infections With ESBL-producing Enterobacteriaceae With ESBL Producing Enterobacteriaceae and Resistance Associated With Fluoroquinolones and Cotrimoxazole (FOSF'HOM) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating oral fosfomycin trometamol for documented male urinary tract infections due to ESBL-producing Enterobacteriaceae with fluoroqu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Tract Infections

Drugs mentioned

• fosfomycin trometamol (fosfomycin trometamol)

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Urinary Tract Infections | Phase 2 | Status: UNKNOWN